Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 9, 2015 - Issue
Submit an article Journal homepage
103
Views
36
CrossRef citations to date
0
Altmetric
Review

Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents

Aleksander Lenert1 Division of Rheumatology, University of Kentucky, Kentucky Clinic, Lexington, KY, USA
&
Petar Lenert2 Division of Immunology, Department of Internal Medicine, The University of Iowa, Iowa City, IA, USACorrespondence[email protected]
Pages 333-347 | Published online: 07 Jan 2015

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Diana Meyler, Abilio Arrascaeta-Llanes, Ravi Gupta & Sanjay Godhwani. (2019) A unique presentation of a rare disease: biopsy proven systemic lupus erythematosus and microscopic polyangitis: an overlap syndrome. Journal of Community Hospital Internal Medicine Perspectives 9:5, pages 433-436.
Read now
Wilma Barcellini, Bruno Fattizzo & Anna Zaninoni. (2018) Current and emerging treatment options for autoimmune hemolytic anemia. Expert Review of Clinical Immunology 14:10, pages 857-872.
Read now
Aleksander Lenert, Timothy B Niewold & Petar Lenert. (2017) Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date. Drug Design, Development and Therapy 11, pages 747-757.
Read now
Shawn Shetty & A. Razzaque Ahmed. (2017) Rituximab in the treatment of pemphigus. Expert Opinion on Orphan Drugs 5:1, pages 99-109.
Read now
Grant H. Moore & Daniel B. Rootman. (2016) Orbital inflammatory disease management. Expert Review of Ophthalmology 11:6, pages 415-428.
Read now

Articles from other publishers (31)

Dhruva Sharma, Neha Sharma & KrishnanGanapathy Subramaniam. (2023) Curbing proteastasis to combat antibody-mediated rejection post lung transplant. Indian Journal of Transplantation 17:1, pages 12.
Crossref
Adél Molnár, Péter Studinger & Nóra Ledó. (2022) Diagnostic and Therapeutic Approach in ANCA-Associated Glomerulonephritis: A Review on Management Strategies. Frontiers in Medicine 9.
Crossref
Elham Ahmadian, Seyed Mahdi Hosseiniyan Khatibi, Sepideh Zununi Vahed & Mohammadreza Ardalan. (2022) Novel treatment options in rituximab-resistant membranous nephropathy patients. International Immunopharmacology 107, pages 108635.
Crossref
Matthew J Mandell, Gatr-Alnada Gheriani, Aleksander Lenert & Petar S Lenert. (2022) Avacopan: An Oral Complement 5a Inhibitor for ANCA-associated Vasculitis. Rheumatology 1:1, pages 23.
Crossref
Ana Merino-Vico, Jan Piet van Hamburg & Sander W. Tas. (2021) B Lineage Cells in ANCA-Associated Vasculitis. International Journal of Molecular Sciences 23:1, pages 387.
Crossref
Joanna Krajewska Wojciechowska, Wojciech Krajewski, Katarzyna Kościelska-Kasprzak & Tomasz Zatoński. (2021) Serum cytokines in ANCA-associated vasculitis: Correlation with disease-related clinical and laboratory findings. Medicina Clínica 157:10, pages 464-472.
Crossref
Joanna Krajewska Wojciechowska, Wojciech Krajewski, Katarzyna Kościelska-Kasprzak & Tomasz Zatoński. (2021) Serum cytokines in ANCA-associated vasculitis: Correlation with disease-related clinical and laboratory findings. Medicina Clínica (English Edition) 157:10, pages 464-472.
Crossref
Laura S. van Dam, Jelle M. Oskam, Sylvia W. A. Kamerling, Eline J. Arends, O. W. Bredewold, Magdalena A. Berkowska, Jacques J. M. van Dongen, Ton J. Rabelink, Cees van Kooten & Y. K. Onno Teng. (2020) Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients. Frontiers in Immunology 11.
Crossref
Luoman Li, Yaxin Jiang, LiLi Su, Deming Feng, Jing Wei & Jian Sun. (2020) Study on the Mechanism of Selective Interaction of BR3 and BCMA with BAFF and APRIL. Protein & Peptide Letters 27:11, pages 1114-1123.
Crossref
Junji Ikeda, Yasuhiro Shimojima, Yoko Usami, Ken-ichi Ueno, Dai Kishida & Yoshiki Sekijima. (2020) Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis. Clinical Rheumatology 39:6, pages 1803-1811.
Crossref
Jessica M. Pouso-Diz, Jose M. Abalo-Lojo & Francisco Gonzalez. (2020) Thyroid eye disease: current and potential medical management. International Ophthalmology 40:4, pages 1035-1048.
Crossref
Benoit Brilland, Anne-Sophie Garnier, Alain Chevailler, Pascale Jeannin, Jean-François Subra & Jean-François Augusto. (2020) Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside. Autoimmunity Reviews 19:1, pages 102424.
Crossref
Chiara Marvisi, Renato Alberto Sinico, Carlo Salvarani, David Jayne, Domenico Prisco, Benjamin Terrier, Giacomo Emmi & Augusto Vaglio. (2019) New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group. Internal and Emergency Medicine 14:8, pages 1193-1197.
Crossref
Uma Fogueri, Wisit Cheungapasitporn, David Bourne, Fernando C. Fervenza & Melanie S. Joy. (2018) Rituximab Exhibits Altered Pharmacokinetics in Patients With Membranous Nephropathy. Annals of Pharmacotherapy 53:4, pages 357-363.
Crossref
Won-Ha Lee, Donggun Seo, Su-Geun Lim & Kyoungho Suk. (2019) Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface. Frontiers in Immunology 10.
Crossref
Daigo Nakazawa, Sakiko Masuda, Utano Tomaru & Akihiro Ishizu. (2018) Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nature Reviews Rheumatology 15:2, pages 91-101.
Crossref
Katrina J. Spensley & Frederick W. K. Tam. (2018) From Renal Biomarkers to Therapeutic Targets: The Use of Monocyte Chemoattractant Protein 1, Transforming Growth Factor-Beta, and Connective Tissue Growth Factor in Diabetic Nephropathy and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. European Medical Journal, pages 70-78.
Crossref
Michael R. Pranzatelli. (2018) Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines. Frontiers in Immunology 9.
Crossref
Francesca Trentin, Mariele Gatto, Margherita Zen, Larosa Maddalena, Linda Nalotto, Francesca Saccon, Elisabetta Zanatta, Luca Iaccarino & Andrea Doria. (2018) Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies. Clinical Reviews in Allergy & Immunology 54:2, pages 331-343.
Crossref
Radim Bečvář. (2018) Novel trends in monitoring and therapy of ANCA associated vasculitides. Vnitřní lékařství 64:2, pages 164-168.
Crossref
Kimberly A. Morishita, Georgina Tiller & David A. Cabral. (2017) Therapeutic Management of Pediatric Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis. Current Treatment Options in Rheumatology 3:4, pages 207-219.
Crossref
Fen Tang, Xiaoqing Chen, Yuxiang Mao, Shangtao Wan, Siming Ai, Huasheng Yang, Guangming Liu, Yusha Zou, Miaoli Lin & Liang Dan. (2017) Orbital fibroblasts of Graves' orbitopathy stimulated with proinflammatory cytokines promote B cell survival by secreting BAFF. Molecular and Cellular Endocrinology 446, pages 1-11.
Crossref
Shingo Nakayamada & Yoshiya Tanaka. (2016) BAFF- and APRIL-targeted therapy in systemic autoimmune diseases. Inflammation and Regeneration 36:1.
Crossref
Pierre-André Jarrot & Gilles Kaplanski. (2016) Pathogenesis of ANCA-associated vasculitis: An update. Autoimmunity Reviews 15:7, pages 704-713.
Crossref
Aleksander Lenert & Qingping Yao. (2016) Macrophage activation syndrome complicating adult onset Still’s disease: A single center case series and comparison with literature. Seminars in Arthritis and Rheumatism 45:6, pages 711-716.
Crossref
Benjamin Chaigne & Loïc Guillevin. (2016) New therapeutic approaches for ANCA-associated vasculitides. La Presse Médicale 45:6, pages e171-e178.
Crossref
Joanna Wojciechowska, Wojciech Krajewski, Piotr Krajewski & Tomasz Kręcicki. (2016) Granulomatosis With Polyangiitis in Otolaryngologist Practice: A Review of Current Knowledge. Clinical and Experimental Otorhinolaryngology 9:1, pages 8-13.
Crossref
Shitong Wei, Yonghua Sun & Hongyu Sha. (2015) Therapeutic targeting of BET protein BRD4 delays murine lupus. International Immunopharmacology 29:2, pages 314-319.
Crossref
Ashish Aggarwal, Aman Sharma, Manish Rathi, Kusum Sharma & Ranjana Walker Minz. (2015) Antineutrophil cytoplasmic antibodies (ANCA): Role in disease pathogenesis, diagnosis, and monitoring ANCA associated vasculitis. Indian Journal of Rheumatology 10, pages S48-S53.
Crossref
Roberta Fenoglio & Dario Roccatello. (2018) Biologic Therapeutic Agents in Nephrology. Giornale di Tecniche Nefrologiche e Dialitiche 27:4, pages 214-220.
Crossref
Kimberly Morishita, Kelly Brown & David Cabral. (2015) Pediatric vasculitis. Current Opinion in Rheumatology 27:5, pages 493-499.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.